Canaan X L.P. (CIK 0001619859)

Latest company ownership

Shares held
2,116,552
Last filed at
May 21, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q3 2025Q4
Shares held
2,000,000
Last filed at
Jan 23, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4
Shares held
602,549
Last filed at
May 28, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4
NXTC - NextCure, Inc.
Role: 10% Owner
Shares held
285,867
Last filed at
May 13, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 28, 2019 May 28, 2019 IDEAYA Biosciences, Inc. 10% Owner Buy 100.0 +400,000 17.69% ✗ $4M
May 13, 2019 May 13, 2019 NextCure, Inc. 10% Owner Buy 85.0 +50,000 2.27% ✗ $750K
May 30, 2018 May 30, 2018 Iterum Therapeutics plc Director Buy 100.0 +506,656 41.31% ✗ $6.6M
May 17, 2018 May 21, 2018 Protagonist Therapeutics, Inc 10% Owner Sell 22.5 -38,968 -1.81% ✗ $237.4K
May 14, 2018 May 16, 2018 Protagonist Therapeutics, Inc 10% Owner Sell 17.5 -164,747 -7.10% ✗ $1.1M
Mar 23, 2018 Mar 26, 2018 Protagonist Therapeutics, Inc 10% Owner Sell 17.5 -59,950 -2.52% ✗ $1.2M
Mar 20, 2018 Mar 22, 2018 Protagonist Therapeutics, Inc 10% Owner Sell 20.0 -39,518 -1.63% ✗ $814.4K
Mar 16, 2018 Mar 19, 2018 Protagonist Therapeutics, Inc 10% Owner Sell 30.0 -20,365 -0.83% ✗ $418.5K
Mar 13, 2018 Mar 15, 2018 Protagonist Therapeutics, Inc 10% Owner Sell 30.0 -13,155 -0.54% ✗ $271.8K
Aug 16, 2016 Aug 16, 2016 Protagonist Therapeutics, Inc Director Buy 100.0 +583,333 31.20% ✗ $7M